Accueil   Diary - News   All news Novadiscovery raises Series A2 financing from Sanofi to advance JINKO

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO

 

 

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform

 

NOVA to develop COVID-19 disease model to support Sanofi’s vaccine and therapeutic efforts

 

 

Lyon, France – 16 February 2021: Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has raised €2.5 million in a Series A2 financing round from Sanofi.

 

 

Read the press release